RUA Life Sciences PLC Result of AGM (2425K)
31 Agosto 2021 - 6:32AM
UK Regulatory
TIDMRUA
RNS Number : 2425K
RUA Life Sciences PLC
31 August 2021
RUA Life Sciences Plc
("RUA Life Sciences", the "Company" or the "Group")
Result of AGM
RUA Life Sciences, the holding company of a group of medical
device businesses focused on the exploitation of the world's
leading long-term implantable biostable polymer (Elast-Eon (TM) ),
announces that all resolutions put to shareholders at its Annual
General Meeting held earlier today, were duly passed. In light of
the risks associated with the coronavirus pandemic, the Board
reluctantly advised shareholders against attending in person and
the vote was taken by way of a poll.
The full details of votes cast are set out below:
Res Votes % Votes Against % Votes Total % I.S.C. Votes Withheld
No. For
-------- ------
01 5,401,382 100.00% 0 0.00% 5,401,382 24.35 0
----- -------- ------ --------- ---------------
02 5,360,836 99.26% 39,726 0.74% 5,400,562 24.34 820
----- -------- ------ --------- ---------------
03 5,401,382 100.00% 0 0.00% 5,401,382 24.35 0
----- -------- ------ --------- ---------------
04 5,401,366 100.00% 16 0.00% 5,401,382 24.35 0
----- -------- ------ --------- ---------------
05 WITHDRAWN
----- --------------------------------------------------------------------------------------
06 5,400,370 99.98% 1,000 0.02% 5,401,370 24.35 12
----- -------- ------ --------- ---------------
07 5,273,860 99.86% 7,494 0.14% 5,281,354 23.81 120,028
----- -------- ------ --------- ---------------
08 5,386,892 99.73% 14,348 0.27% 5,401,240 24.35 142
----- -------- ------ --------- ---------------
09 5,392,646 99.84% 8,594 0.16% 5,401,240 24.35 142
----- -------- ------ --------- ---------------
In advance of the AGM, questions were received from shareholders
unable to attend the meeting due to the advice given. Those
questions and answers will shortly be published on the Company's
website.
For further information contact:
RUA Life Sciences
Bill Brown, Chairman Tel: +44 (0)1294 317073
Dr Caroline Stretton, Group MD Tel: +44 (0)1294 317073
Shore Capital (Nominated Adviser and Joint Broker) Tel: +44 (0)20 7408 4080
Tom Griffiths/David Coaten
Cenkos Securities plc (Joint Broker) Tel: +44 (0)20 7397 8900
Max Gould, Giles Balleny (Corporate Finance)
Michael Johnson (Sales)
About RUA Life Sciences
The RUA Life Sciences group was created in April 2020 when RUA
Life Sciences Plc (formerly known as AorTech International Plc)
acquired RUA Medical Devices Limited to create a fully formed
medical device business. RUA Life Sciences is the holding company
of the Group's four trading businesses, each exploiting the Group's
patented polymer technology.
Our vision is to improve the lives of millions of patients by
enabling medical devices with ElastEon (TM) , the world's leading
long-term implantable polyurethane.
Whether it is licensing ElastEon (TM) , manufacturing a device
or component, or developing next generation medical devices, a RUA
Life Sciences business is pursuing our vision.
ElastEon(TM)'s biostability is comparable to silicone while
exhibiting excellent mechanical, blood contacting and flex-fatigue
properties. These polymers can be processed using conventional
thermoplastic extrusion and moulding techniques. With over 7
million implants and 14 years of successful clinical use, RUA's
polymers are proven in long-term life enabling applications.
The Group's four business units are:
RUA Medical End-to-end contract developer and manufacturer
: of medical devices and implantable fabric specialist.
RUA Biomaterials Licensor of Elast-Eon (TM) polymers to the medical
: device industry.
RUA Vascular: Development of large bore polymer sealed grafts
and soft tissue patches.
RUA Structural Development of tri leaflet polymeric heart valves.
Heart :
A copy of this announcement will be available shortly at
www.rualifesciences.com/investor-relations/regulatory-news-alerts
.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGPBMBTMTJJBMB
(END) Dow Jones Newswires
August 31, 2021 07:32 ET (11:32 GMT)
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Rua Life Sciences (LSE:RUA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024